BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND GNAQ, P50148, 2776, ENSG00000156052, G-ALPHA-q, RP11-494N1_1, GAQ
121084 results:

  • 1. Physician preferences for an electronic lung cancer screening decision aid.
    Morgan O; Schnur JB; Diefenbach MA; Kale MS
    Am J Manag Care; 2024 May; 30(6 Spec No.):SP445-SP451. PubMed ID: 38820185
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Predicting lung cancer Survival to the Future: Population-Based cancer Survival Modeling Study.
    Meng FT; Jhuang JR; Peng YT; Chiang CJ; Yang YW; Huang CY; Huang KP; Lee WC
    JMIR Public Health Surveill; 2024 May; 10():e46737. PubMed ID: 38819904
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Patient lung cancer Screening Decisions and Environmental and Psychosocial Factors.
    Richmond J; Fernandez JR; Bonnet K; Sellers A; Schlundt DG; Forde AT; Wilkins CH; Aldrich MC
    JAMA Netw Open; 2024 May; 7(5):e2412880. PubMed ID: 38819825
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Geriatric End-of-Life Screening Tool Prediction of 6-Month Mortality in Older Patients.
    Haimovich AD; Burke RC; Nathanson LA; Rubins D; Taylor RA; Kross EK; Ouchi K; Shapiro NI; Schonberg MA
    JAMA Netw Open; 2024 May; 7(5):e2414213. PubMed ID: 38819823
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effect of body mass index and cholesterol-rich apolipoprotein-B-containing lipoproteins on clinical outcome in NSCLC patients treated with immune checkpoint inhibitors-based therapy: A retrospective analysis.
    Hu Z; Zheng Y; Zheng J; Wang Y; Liao J; Liu Z; Li J; Cui H
    Cancer Med; 2024 Jun; 13(11):e7241. PubMed ID: 38819098
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. In-vitro Cytotoxicity Investigations for Phytoconstituents of Saudi Medicinal Plants With Putative Ocular Effects.
    Alghamdi AH; Ahmed AAE; Abdalgadir H; Bashir M; Khalid A; Abdalla AN; Elzubier ME; Adnan Almaimani R; Refaat B; Alzahrani K; Alghamdi SMS; Gul S
    Integr Cancer Ther; 2024; 23():15347354241256649. PubMed ID: 38819027
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The incidence of and risk factors for radiation pneumonitis in patients treated with simultaneous bevacizumab and thoracic radiotherapy.
    Chen F; Niu J; Wang M; Zhu H; Guo Z
    Radiat Oncol; 2024 May; 19(1):67. PubMed ID: 38816745
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Machine learning models for predicting blood pressure phenotypes by combining multiple polygenic risk scores.
    Hrytsenko Y; Shea B; Elgart M; Kurniansyah N; Lyons G; Morrison AC; Carson AP; Haring B; Mitchell BD; Psaty BM; Jaeger BC; Gu CC; Kooperberg C; Levy D; Lloyd-Jones D; Choi E; Brody JA; Smith JA; Rotter JI; Moll M; Fornage M; Simon N; Castaldi P; Casanova R; Chung RH; Kaplan R; Loos RJF; Kardia SLR; Rich SS; Redline S; Kelly T; O'Connor T; Zhao W; Kim W; Guo X; Ida Chen YD; ; Sofer T
    Sci Rep; 2024 May; 14(1):12436. PubMed ID: 38816422
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Targeting nerve growth factor-mediated osteosarcoma metastasis: mechanistic insights and therapeutic opportunities using larotrectinib.
    Hou CH; Chen WL; Lin CY
    Cell Death Dis; 2024 May; 15(5):381. PubMed ID: 38816365
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Chest Magnetic Resonance Imaging: Advances and Clinical Care.
    Ozawa Y; Nagata H; Ueda T; Oshima Y; Hamabuchi N; Yoshikawa T; Takenaka D; Ohno Y
    Clin Chest Med; 2024 Jun; 45(2):505-529. PubMed ID: 38816103
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Juglone triggers apoptosis of non-small cell lung cancer through the reactive oxygen species -mediated PI3K/Akt pathway.
    Zhong J; Hua Y; Zou S; Wang B
    PLoS One; 2024; 19(5):e0299921. PubMed ID: 38814975
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. International Cost-Effectiveness Analysis of Durvalumab in Stage III Non-Small Cell lung cancer.
    Kareff SA; Han S; Haaland B; Jani CJ; Kohli R; Aguiar PN; Huang Y; Soo RA; Rodríguez-Perez Á; García-Foncillas J; Dómine M; de Lima Lopes G
    JAMA Netw Open; 2024 May; 7(5):e2413938. PubMed ID: 38814640
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pulmonary lesion after surgery for renal cancer: progression or new primary?
    Cignoli D; Bandiera A; Rosiello G; Castorina R; Re C; Cei F; Musso G; Belladelli F; Freschi M; Lucianò R; Raggi D; Negri G; Necchi A; Salonia A; Montorsi F; Larcher A; Capitanio U
    World J Urol; 2024 May; 42(1):361. PubMed ID: 38814376
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Impacts of Chlorine 1-3 ıon channels on localized bladder neoplasms.
    Muslum O; Ahmet K; Ebru O; Ahmet T; Tunc O; Ahmet K; Irfan O
    Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):76-81. PubMed ID: 38814232
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. High expression of HMBOX1 promotes the progression of lung squamous cell carcinoma.
    Chen X; Zha G; Li C; Wang K
    Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):198-203. PubMed ID: 38814216
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Quantitative systems pharmacology modeling of macrophage-targeted therapy combined with PD-L1 inhibition in advanced NSCLC.
    Wang H; Arulraj T; Anbari S; Popel AS
    Clin Transl Sci; 2024 Jun; 17(6):e13811. PubMed ID: 38814167
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Management and prognosis of patients with cancer of unknown primary: 20 years of experience.
    Bardakçi M; Algin E; Düğeroğlu B; Bal Ö; Köş FT; Uncu D
    Turk J Med Sci; 2023; 53(6):1722-1731. PubMed ID: 38813492
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Sodium-fluorescein-guided awake surgery for cerebral metastases located in eloquent brain areas: technical notes and preliminary experiences.
    Türkkan A; Ocak P; Khezri MK; Bekar A
    Turk J Med Sci; 2024; 54(1):220-228. PubMed ID: 38812653
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Exosomal EGFR and miR-381-3P Mediate HPV-16 E7 Oncoprotein-Induced Angiogenesis of Non-Small Cell lung cancer.
    Zhan R; Yu H; Zhang G; Ding Q; Li H; Li X; Tang X
    Front Biosci (Landmark Ed); 2024 May; 29(5):189. PubMed ID: 38812317
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study.
    Xie M; Vuko M; Rodriguez-Canales J; Zimmermann J; Schick M; O'Brien C; Paz-Ares L; Goldman JW; Garassino MC; Gay CM; Heymach JV; Jiang H; Barrett JC; Stewart RA; Lai Z; Byers LA; Rudin CM; Shrestha Y
    Mol Cancer; 2024 May; 23(1):115. PubMed ID: 38811992
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6055.